Menu

News

  • Apr 17, 2019
    Innovative Breast Center Showcases New Strategies in the Fight Against Cancer
    As part of their whole-person care strategy, Dr. Wilson’s practice uses a new tool, known as MarginProbe, to ensure that a safe margin of tissue is removed around a cancerous tumor as that tumor is removed during surgery.
    READ MORE
  • Mar 26, 2019
    Another Major Accomplishment for Dune Medical as it Launches its First In-Man Trial for its Revolutionary Smart Biopsy Device
    Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radio-frequency (RF) spectroscopy technology.
    READ MORE
  • Mar 21, 2019
    The 24th Multidisciplinary Symposium on Breast Disease: Our Favorite Moments
    Lori Chmura and Tom Melba attended the 24th Annual Multidisciplinary Symposium on Breast Disease to exhibit MarginProbe, the only FDA approved intraoperative tool for margin assessment. Here are some of their favorite moments from the symposium.
    READ MORE
  • Mar 18, 2019
    MarginProbe Global Study Investigators Share Experiences during San Antonio Breast Cancer Symposium
    Global breast surgeon thought leaders from the United States, Germany, Israel, the UK and Japan came together during an international investigator reception at the San Antonio Breast Cancer Symposium, hosted by Dune Medical.
    READ MORE
  • Feb 22, 2019
    Lori Chmura discusses her experience in the medtech industry on Medtech Women @ SEMDA Webinar
    After being awarded Medtech Woman of the Year for 2018 by MW@S, Lori joined Jason Rupp on the webinar to discuss her work with Dune Medical Devices, the challenges she faced as a woman in the medtech industry, and more.
    READ MORE

Events

Event Information:

  • Thu
    07
    Mar
    2019
    Sun
    10
    Mar
    2019

    Miami Breast

    Miami, FL

    The 36th Annual Miami Breast Cancer Conference will bring together surgical, medical, and radiation oncologists, as well as geneticists, pathologists, radiologists, and supportive care specialists, to foster awareness of state-of-the-art treatments for all stages and subtypes of breast cancer.

×
Search